Serial Number:
85804016
Mark:
Status:
Section 8 and 15-accepted and acknowledged
Status Date:
12-15-2021
Filing Date:
Registration Number:
4813223
Registration Date:
09-15-2015
Industrial chemicals; active chemical ingredients for use in the manufacture of chemotherapeutic medicines; active chemical ingredients for use in the manufacture of medicines for treating a wide range of cancers, including hematological malignancies, many types of carcinoma, and soft tissue sarcomas, breast and ovarian cancer, gastric cancer, lung cancer and lymphomas, acute myeloid leukemia, bladder cancer, metastatic breast cancer, metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoblastic leukaemia, breast cancer and non-small cell lung cancer, ovarian cancer and lung cancer, colon cancer, in particular, in combination with other chemotherapy, hairy cell leukemia (HCL) and multiple sclerosis, hematological malignancies, T-cell acute lymphoblastic leukemia, relapsed or refractory acute lymphoblastic leukaemia (ALL) in children after at least two other types of treatment have failed, acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML), myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML), immunosuppressant to prevent rejection in organ transplantation, it is especially useful in kidney transplants, to prevent rejection of organ transplants and treatment of renal cell cancer and other tumors, aggressive metastatic or locally advanced breast cancer, multiple myeloma, hematological disorders known as myelodysplastic syndromes (MDS), chronic lymphocytic leukemia, lymphomas and sarcoma, hormone-regractory prostate cancer, lymphoma and multiple myeloma, diseases of the immunological system, namely, auto-immune diseases, and prevention of organ rejection after transplantation; chemical preparations for use as intermediates for manufacture of finished active pharmaceutical ingredients for treating a wide range of cancers, diseases of the immunological system, namely, auto-immune diseases, and prevention of organ rejection after transplantation Pharmaceutical and veterinary preparations for treating various types of cancers, diseases of the immunological system, namely, auto-immune diseases, and for prevention of organ rejection after transplantation; chemical preparations for pharmaceutical use, namely, for treating cancer and oncology diseases; chemical reagents for medical or veterinary use; pharmaceutical preparations for medical use for treating mainly cancer and oncology diseases; pharmaceutical preparations for use in chemotherapy; antibiotics Advertising, business management; business administration, business development; marketing services; office functions; regulatory submission management services, namely, assisting others in the preparation and deposit of regulatory documents in the field of veterinary and pharmaceutical preparations Scientific and technological services, namely, research and design in the field of chemicals, active pharmaceutical ingredients and pharmaceutical finished products and medicines; industrial analysis and research services in the field of chemicals, active pharmaceutical ingredients and pharmaceutical finished products and medicines; development of pharmaceutical preparations and medicines; research in the field of development and testing of pharmaceutical preparations Legal services, namely, preparation and deposit for others of regulatory documents in the fields of veterinary and pharmaceutical preparations; patent search services for others
Mark Description:
The mark consists of an abstract drawing featuring four dark rectangles of various sizes around a light rectangle. One dark rectangle is inside the light area.
Class:
Legal services
Type of Mark:
Trademark
Published for Opposition Date:
04-22-2014
Owner:
Mark Drawing Status:
Design Only
Abandon Date:
N/A
Business Name:
HOLLAND & KNIGHT
Correspondent Name:
